¿Le interesan nuestros Másteres? Llámenos al
+34 932 478 023

Mario Herrera Marschitz

Mario Herrera Marschitz


Profesor de Farmacología de la Universidad de Chile, Santiago de Chile, Chile.


Máster en Neurociencia Experimental y Clínica

Universidad de Murcia

Síntesis curricular

Present Position:

Full Professor, Programme of Molecular & Clinical Pharmacology, ICBM; Millenium Institute-BNI-Chile (BNI P09-015-F); Medical Faculty, University of Chile

Other positions:
Professor at the Dept. of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden (up to 2004). Visiting Professor, University of Cagliari, Regional Government of the Autonomous Region of Sardinia, Italy (2011). Awarded Visiting Lecturer by Univertitat Jaume I, Castellon, Spain; within the framework of the UJI- Ambassadors Programme and EU- July, 2013 (2014).

Degrees: Dr. Med. Sci., Karolinska Institutet, Stockholm, Sweden, 1986; Docent of Pharmacology, Karolinska Institutet, Stockholm, Sweden, 1991; PhD, Comenius University, Bratislava, Czechoslovakia, 1978. Fellow of the Swedish Society of Medicine (Nr. 1070945).

Awards: Obtained all major Awards granted by the Swedish Medical Research Council (MFR) (i) Postdoc (forskarassistent) (1987-1990). (ii) MFR-Scientist (a tenure-track position at the level of Assoc. Professor) (forskare) (1993-1998). (iii) Sabbatical MFR-Research period in USA (Dept. of Anatomy, Tennessee University, Memphis, TN, USA; 1996-1997).

In 1999, nominated for a tenure position at the Karolinska Institutet, Stockholm, Sweden. In 2001, invited to chair (Director) the Programme of Molecular & Clinical Pharmacology, ICBM, Medical Faculty, University of Chile, Santiago, Chile (2001-2007).
         Dopamine medal, award for a major contribution in monoamine research, Nobel Forum, Karolinska Institutet, December 5, 2008 (Chemical Signalling in the Nervous System in Health and Disease: Nils-Åke Hillarp’s Legacy). Eiselsberg-Preis and Foederungspreis der Stadt Wien 1997. Hoechst Preis 1998. Other minor awards.

Scientific production

Herrera-Marschitz has authored more than 200 scientific papers, over 150 cited by Pub Med, and with more than 1500 citations, according to (2007).

Associate Editor of Neurotoxicity Research (Springer, USA). Editor-in-Chief of Amino Acids (Springer Wien New York) up to 2008. Associated Editor Journal of Amino Acids (SAGE-Hindawi Access to Research; International). Member of the Editorial Board of several other international journals.

External reviewer for several international founding institutions, including the FWF-Austrian Science Fund (Weyringergasse 35, 1040 Vienna, Austria); Bundensministerium für Bildung, Wissenschaft und Kultur (Minoritenplatz 5, A-1014 Wien, Austria) (2000-2008); Technion-Israel Institute of Technology; The Ruth&Bruce Rappaport Faculty of Medicine, Haifa, Israel (2007); Hungarian Scientific Research Fund (OTKA), Hungary; (,; the neurological Foundation of New Zealand (;, New Zeland; Wellbeing of Women foundation (Charity Registration No 239281), London, UK. (;  Czech Science foundation (Department of Medical and Biological Sciences;;, Czech Republic. CONICYT-Chile, Chile.

Research grants

In Sweden: Awarded with independent research grants by the Swedish Medical Research Council since 1988 (Nr. 8669), successfully renewed and expanded up to 2002.

In Chile: Herrera-Marschitz established his own research group in 2001, supported by national (FONDECYT-1000626, 1030521, 1080447, 1095021, 1110263, 1120079; 1130012; CONICYT/DAAD 186-10-2006, 1378-090529; ICBM-Enlace 2006; DID, 12-02/8-2) and international (Swedish Medical Research Council; KI-Stiftelsen; CMA/Microdialysis AB, Sweden; ALFA-NEURALNET-2006-2008; IBRO Latin American Regional Committee

LARC-2006-2007]; Foundation MH-Marschitz, Sweden; NIH TJU080-04000-R795011 [YIsrael] [Programme Molecular & Pharmacology, ICBM, Medical Faculty, University of Chile/NIH-USA, 2007

grants. Co-investigator of the Scientific Millenium Initiative BNI-Chile (P09-015-F) (2011-2021).
Line of Research: Pharmacology, Neuropharmacology, Neurochemistry, Neonatology.


See PUBMED: 157 opuses up to October 2013.
Recent publications
Israel Y, Rivera-Meza M, Karahanian E, Quintanilla ME, Tampier L, Morales P, Herrera-Marschitz M. (2013) Gene specific modifications unravel ethanol and acetaldehyde actions.

Front Behav Neurosci. 2013;7:80. doi: 10.3389/fnbeh.2013.00080.
Ortega EJ, Gonzalez-Lira V, Horrillo I, Herrera-Marschitz M, Felipe Callado L, Javier Meana J. (2013) Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain. Eur J Pharmacol 709: 13-19.

Tampier L, Quintanilla ME, Karahanian E, Rivera-Meza M, Herrera-Marschitz M, Israel Y (2013) The Alcohol Deprivation Effect: Marked Inhibition by Anticatalase Gene Administration into the Ventral Tegmental Area in Rats. Alcohol Clin Exp Res. 37: 1278-1285.

Schmitt A, Leonardi-Essmann F, Durrenberger PF, Wichert SP, Spanagel R, Arzberger T, Kretzschmar H, Zink M, Herrera-Marschitz M, Reynolds R, Rossner MJ, Falkai P, Gebicke-Haerter PJ (2012) Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients. Eur Arch Psychiatry Clin Neurosci 262: 565-577.

Allende-Castro C, Espina-Marchant P, Bustamante D, Rojas-Mancilla E, Neira T, Gutierrez-Hernandez MA, Esmar D, Valdes JL, Morales P, Gebicke-Haerter PJ, Herrera-Marschitz M (2012) Further studies on the hypothesis of PARP-1 inhibition as a strategy for lessening the long-term effects produced by perinatal asphyxia: effects of nicotinamide and theophylline on PARP-1 activity in brain and peripheral tissue: nicotinamide and theophylline on PARP-1 activity. Neurotox Res 22: 79-90.

Quintanilla ME, Tampier L, Karahanian E, Rivera-Meza M, Herrera-Marschitz M, Israel Y (2012) Reward and relapse: complete gene-induced dissociation in an animal model of alcohol dependence. Alcohol Clin Exp Res 36: 517-522.